ECT2 and breast carcinoma: The results showed that ECT2 deletion associated growth retardation of breast cancer cells could be reverted, to certain extent, by forced expression of MDM2 or USP7/wt (Figure 6E and 6F; Figure S5B and S5C), but not USP7/C223S (Figure S5D and S5E).